• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Astrazeneca Pharma India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
506820
INE203A01020
349.116
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ASTRAZEN
107.66
20609.75
EPS(TTM)
Face Value()
Div & Yield %
76.57
2
0.44
 

Niyogin Fintech reports consolidated net profit of Rs 0.71 crore in the March 2026 quarter
May 15,2026
Net profit of Niyogin Fintech reported to Rs 0.71 crore in the quarter ended March 2026 as against net loss of Rs 0.33 crore during the previous quarter ended March 2025. Sales rose 3.04% to Rs 71.97 crore in the quarter ended March 2026 as against Rs 69.85 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.47 crore in the year ended March 2026 as against net loss of Rs 15.89 crore during the previous year ended March 2025. Sales declined 5.61% to Rs 286.93 crore in the year ended March 2026 as against Rs 303.98 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales71.9769.85 3 286.93303.98 -6
OPM %8.420.39 -1.32-1.76 -
PBDT4.11-0.77 LP 14.49-12.73 LP
PBT1.42-3.10 LP 4.18-22.27 LP
NP0.71-0.33 LP -0.47-15.89 97